Home » News
No.Date of Intimation Gist of news updated on Stock Exchange
110/05/2017 Outcome of Board Meeting
View Outcome of Board Meeting
215/02/2017 Outcome of Board Meeting & Quarterly Results
View Outcome of Board Meeting
View Results
304/02/2017 Intimation of Board Meeting & Trading window closure View Notice
412/23/2016 Resignation of independent director – Ms Dharmishthaben Raval View Notice
508/11/2016 Postal Ballot Results View Results
616/10/2016 Intimation of Board Meeting & Trading window closure View Notice
704/10/2016 Postal ballot notice intimation to Bombay Stock Exchange View Notice
823/09/2016 Postal ballot notice. View Notice View / Download Form
923/09/2016 Outcome of board meeting View Outcome
1025/08/2016 NOTICE is hereby given that the 35th Annual General Meeting of the members of the Company will be held at Plot no. 69-C, GIDC Industrial Estate, Vapi, Dist. Valsad, Gujarat-396 195 on Wednesday, 14st September, 2016 at 12 Noon to transact the Ordinary and Special business set out in the Notice dated 11th August, 2016 sent to the members. View Notice
1111/08/2016 Outcome of Board Meeting View Outcome
1202/07/2016 Notice of Board Meeting
Intimation send to Stock Exchanges for meeting to be held on 11th August, 2016, to consider the unaudited financial results of the company for the quarter ended 30thJune 2016. View Notice
1303/05/2016 Notice of Board Meeting
Intimation send to Stock Exchanges for meeting to be held on 11th May, 2016, to consider the audited financial results of the company for the quarter and year ended 31stMarch 2016. View Notice
1415/01/2016 The Board of Directors at its meeting held today, considered and approved Audited Financial Results for the Half year ended 30th September, 2015, for the purpose of submission of Miscellaneous Application for deregistration of the Company from BIFR as per SICA 1985.

Gujarat Themis Biosyn Limited has recorded income from operations of INR 16.51 crores & Net Profit of INR. 2.31 crores as per the approved Audited Accounts for the half year ended 30th September, 2015. The unaudited Financial Results as per the Listing Agreement were submitted to the Stock Exchange on 5th November, 2015.

The Company’s Net Worth has turned positive much before as envisaged in the Scheme approved by the Hon’ble Board for Industrial and Financial Reconstruction (BIRF).
1505/11/2015 The Board of Directors at its meeting held on 5-11-2015, considered and approved Unaudited Financial Results for the Quarter /Half year ended 30th September, 2015.
1622/09/2015 The 34th Annual General Meeting of Gujarat Themis Biosyn Ltd. held on Monday, 21st September, 2015 at 69/C GIDC Industrial Estate, Vapi – 396 195, Dist. Valsad, Gujarat and approved the Ordinary & Special business set out in the notice dated 28-5-2015 by the members. View AGM Outcome
1731/08/2015 NOTICE is hereby given that the 34th Annual General Meeting of the members of the Company will be held at Plot no. 69-C, GIDC Industrial Estate, Vapi, Dist. Valsad, Gujarat-396 195 on Monday, 21st September, 2015 at 12 Noon to transact the Ordinary and Special business set out in the Notice dated 28th May, 2015 sent to the members. View Notice
1811/08/2015 Press Release
1. Gujarat Themis Biosyn Ltd. is pleased to announce operating income of Rs. 826.61 Lacs during the quarter ended 30th June, 2015 against Rs. 804.89 Lacs achieved during the quarter ended 31st March, 2015.

2. The net profit amounted to Rs. 122.60 Lacs during the quarter ended 30th June, 2015 against Rs. 84.66 Lacs recorded during the quarter ended 31st March, 2015.

3. The company has earned EPS (not annualized) of Rs. 0.84 per share of Rs. 5/- each against Rs. 0.58 for the quarter ended 31st March, 2015.

4. The net worth of the Company has become positive during the quarter ended 30th June, 2015 much ahead as envisaged in the Scheme of Rehabilitation approved by the BIFR. The approved scheme envisaged positive networth during the year 2018-19.
1929/05/2015 Press Release
1. The Income from operations of Gujarat Themis Biosyn Limited (A BIRF Company) is as per the plan envisaged by the Management of the Company utilizing capacity to the fullest extent.

2. The Income from operations during the year ended 31st March, 2015 stood at Rs.3144.02 lakhs as compared to Rs. 3023.03 lakhs during the year ended 31st March, 2014.

3. Net Profit improved to Rs. 459.41 lakhs during the period under consideration compared to Rs. 452.60 lakhs during the last year.

4. EPS (Basic) at Rs. 3.16 for the current year compared to Rs. 3.12 during the last year.

5. Barring unforeseen circumstances, the Company expects to wipe off the negative net worth in 2015-16 much before the period for which the revival scheme is approved by BIFR.
2028/05/2015 The Board of Directors of the Company at its meeting held on 28th May, 2015, discussed and approved the following matters:
1. Appointment of Mr. Siddharth Y. Kusumgar (DIN 01676799) as an Additional Independent Director & also inducted him as a member of Audit Committee.

Audited Financial Results for the quarter and year ended 31st March, 2015. The Audit Committee of the Company earlier had also reviewed the aforesaid accounts.

3. Formulated and adopted 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' (Code of Fair Disclosure) of the Company (under Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015).

4. Formulated and approved 'Code of Conduct for Prohibition of Insider Trading' (Code of Conduct) of the Company (under Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015).
2125/03/2015 The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 25th March, 2015 approved the following.
1. Dr. Vikram D. Sanghvi has been appointed an Independent Director on the Board of the Company w.e.f. 25th March, 2015.

2. Mr. Hinesh Doshi has been appointed as an Alternate Director to Mr. J. H. Choi with immediate effect.

3. Appointment of whole time Practicing Secretary Mr. Manish R Desai as Secretarial Auditor for conducting Secretarial Audit for the F.Y 2014-15.
2217/03/2015 The Board of Directors of the Company at its meeting held on 17th March, 2015, discussed and approved the following matters
1. Resignation of Mr. Hinesh Doshi as Alternate Director to Mr. S.S. Lee has been accepted with immediate effect.

2. Mr.Bharat A. Desai has been appointed as Chief Financial Officer (CFO) of the Company w.e.f. 17th March, 2015.
2306/02/2015 The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 6th February, 2015 approved the following.
1. Unaudited Financial Results for the quarter ended 31st December, 2014.

i. The income from operations of Gujarat Themis Biosyn Limited (A BIFR referred Company) is as per the plans envisaged by the Management utilizing capacity to the fullest extent.

ii. Income from operations recorded Rs. 2339.13 Lacs during the current nine months ended December, 2014 as against Rs. 2294.10 lacs during the corresponding period last year.

iii. Net profit improved to Rs. 374.75 lacs during the current nine months as against Rs. 317.64 lacs during the corresponding period of the previous year.

iv. EPS (Basic) at Rs.2.58 for the current nine months ended December,2014 as compared to Rs.2.19 during the corresponding period of the last year.

v. Barring unforeseen circumstances, the Company expects to wipe off the negative net worth in 2015-16.

2. The Company has entered into an agreement for manufacturing and supply of finished product to M/s. Lupin Limited on revised terms during the period from 1st April, 2015 to 31st March, 2018.
2404/11/2014 The Unaudited Financial Results for the Quarter & Half year ended 30th September, 2014 approved by the Board of Directors on 4-11-2014.
1. Income from operations recorded Rs. 1549.68 Lacs during the current Six months ended September, 2014 as against Rs. 1564.29 lacs during the corresponding period of the last year.

2. Net profit increase to Rs. 237.35 lacs during the current Six months as against Rs.206.74 lacs during the corresponding period of the previous year.
2506/08/2014 The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 6th August, 2014 considered and approved the following:
1. Unaudited Financial Results for the quarter ended 30th June, 2014

2. Mr. A.B Shah’s resignation as nominee director of GIIC Ltd. was accepted by the Board.

3. Mr. Rajneesh Anand, President & CEO of the Company stepped down with effect from 7th August, 2014. His services will however be available to the Company as a Consultant from the same date.

4. The appointment of Mr. Vikas Tarekar, Company Secretary was approved by the Board.

5. Mr. Tapas Guha was appointed as CEO of the Company with effect from 7th August, 2014.

6. 33rd Annual General Meeting will be held on Monday, 29th September, 2014 at Registered Office address at Vapi at 12 noon and Share Transfer Register & Register of Members will remain close during Tuesday, 23rd September, 2014 to Monday, 29th September, 2014 (both days inclusive).
2601/08/2014 In order to comply with BIFR order dated 20th November, 2013 as well as SEBI order dated 28th March, 2014 to increase the public shareholding from 15.21% to 25% by 19th August, 2014. One of the promoters, M/s. Pharmaceutical Business Group (India) Ltd has offered for sale of 14,23,000 equity shares (approximately 9.79%) of the face value of Rs.5 each, by way of an offer for sale through the Stock Exchange mechanism and the sale shall take place on August 7, 2014.
2715/05/2014 BIFR referred Gujarat Themis Biosyn Ltd., has significantly surpassed the profitability projections as per scheme of Rehabilitation.

Net Profit for the year ended 31st March, 2014 was Rs. 452.60 lakhs as against net profit of Rs. 106.98 lakhs for the year ended 31st March, 2013.

The negative Net worth of the Company has come down to Rs.534 lakhs as on 31st March 2014 as against Rs. 987 lakhs on 31st March 2013.

EPS for the current year stood at Rs. 3.12 as against Rs. 0.75 in the last year.
2803/04/2014 In line with order passed by BIFR on 20th November, 2013 and 2nd January 2014, SEBI passed an order dated 28th March, 2014 allowing the Company to extend the time to comply with minimum public shareholding on or before 19th August, 2014. Also the Company allowed to increase in equity shares from 14,71,250 to 18,96,500 of Rs. 5/- each fully paid up, through public offer or private offer or through any other mode as well as at price as permitted under regulatory frame work and pricing guidelines of SEBI.

Pursuant to para 12.9 of Order dated 12th January, 2012, the Hon’ble BIFR directed Gujarat Industrial Investment Corporation Ltd. (GIIC Ltd.) to accept principal amount of unsecured loan of Rs. 26.00 lakhs in three equal yearly installments commencing from 1st April, 2011. As per the communication received from GIIC Ltd., the Company has paid an amount of Rs. 31.00 Lakhs (Rupees Thirty one lakhs only) to GIIC Ltd. as full and final settlement payment towards their unsecured loan of Rs. 26.00 Lakhs & Rs.5 Lakhs paid as goodwill, in compliance with the BIFR order dated 12th January, 2012.

The Company has complied with majority of BIFR directives and regularly making its repayment of Bank loans.
2910/02/2014 Gujarat Themis Biosyn Ltd. has recorded turnover of Rs. 2294.10 Lakhs for the current nine months ended 31st December, 2013, as compared to Rs.2104.08 Lakhs during the corresponding period ended 31st December, 2012.

The Company recorded Net Profit of Rs.317.64 Lakhs for the current nine months ended 31st December, 2013 as compared to Rs.111.56 Lakhs during the corresponding period ended 31st December, 2012.

The profit generation recorded exceeds the BIFR approved Scheme for the period under reference.
3012/11/2013 Gujarat Themis Biosyn Limited (GTBL) for which Rehabilitation Scheme was sanctioned by Board for Industrial Reconstruction (BIFR) on 12.01.2012.

The Company under the umbrella of Themis Medicare’s management has started yielding positive results.

The Company has a long term contract with a Pharma major to manufacture Active Pharmaceutical Ingredient (API).

GTBL started positive profits from September 2012 quarter and thereafter the profits have been consistently on rise.

Whereas in the quarter ended June 2013 profit of Rs. 84.78 lakhs was recorded and for the current quarter ended September 2013 net profit increased to Rs. 121.96 lakhs, sizably surpassing the yearly profit of Rs. 106.98 lakhs for the year 2012-13.

GTBL has complied with majority of BIFR directives and is regular in its repayment of Bank loans.